China's Active Pharmaceutical Ingredients Industry Analysis - Top 10 Pharmaceutical Formulations by Sales (Global) in 2022: Sacubitril/Valsartan

In 2022, the global pharmaceutical market witnessed significant sales of various formulations. Among them, the top-selling product was Sacubitril/Valsartan. This combination drug, used in the treatment of heart failure, showed remarkable performance in terms of revenue generation.

Sacubitril/Valsartan, marketed under the brand name Entresto by Novartis, emerged as the leading pharmaceutical formulation in terms of sales worldwide. This medication combines sacubitril, a neprilysin inhibitor, with valsartan, an angiotensin receptor blocker. The synergistic effect of these two components helps to enhance cardiac performance and reduce the risk of cardiovascular events in patients with heart failure. The success of Sacubitril/Valsartan can be attributed to its proven efficacy and the growing prevalence of heart failure worldwide.

Top 3 Countries with the Highest Consumption of Pharmaceutical Formulations (Global) in 2022: China, the United States, Brazil

When analyzing the global consumption of pharmaceutical formulations in 2022, China emerged as the leading consumer. The vast population and increasing healthcare needs in China contributed to its position at the top of the list. The United States followed closely, reflecting the high demand for pharmaceutical products in the country. Brazil secured the third spot, indicating the significant consumption of pharmaceutical formulations in South America.

Top Pharmaceutical Companies by Global Consumption of Pharmaceutical Formulations in 2022: Novartis, Hypera Pharma, Glenmark Pharm

In terms of global consumption, Novartis, a Swiss multinational pharmaceutical company, claimed the top spot as the leading pharmaceutical company in 2022. Novartis's success can be attributed to its diverse portfolio of innovative pharmaceutical formulations and its strong global presence.

Hypera Pharma, a Brazilian pharmaceutical company, secured a prominent position in the rankings. With a focus on research and development, Hypera Pharma has been able to provide effective and affordable pharmaceutical formulations to meet the healthcare needs of the Brazilian population.

Glenmark Pharm, an Indian pharmaceutical company, also emerged as a key player in the global market. Through its commitment to quality and affordable healthcare solutions, Glenmark Pharm has gained recognition and witnessed significant consumption of its pharmaceutical formulations.

These rankings reflect the evolving landscape of the global pharmaceutical market in 2022. The success of Sacubitril/Valsartan as the top-selling formulation, along with the dominance of Novartis and the significant consumption in China, the United States, and Brazil, highlights the importance of innovation, market presence, and meeting the healthcare needs of diverse populations in the pharmaceutical industry.